Showing 6,201 - 6,220 results of 14,107 for search '(( significant decrease decrease ) OR ( significant ((i decrease) OR (a decrease)) ))~', query time: 0.48s Refine Results
  1. 6201
  2. 6202

    The head-withdrawal threshold of naïve rats receiving CGRP. by Hiroharu Maegawa (8087543)

    Published 2025
    “…In naïve rats receiving CGRP, a significant decrease was found at 1 day after the CGRP administration as compared to that before administration. * <i>p</i> < 0.05. …”
  3. 6203
  4. 6204
  5. 6205
  6. 6206

    Scores vs Skip ratios on single-agent task. by Hongjie Zhang (136127)

    Published 2025
    “…The inferences reduction significantly decreases the time and FLOPs required by the <i>LazyAct</i> algorithm to complete tasks. …”
  7. 6207

    Time(s) and GFLOPs savings of single-agent tasks. by Hongjie Zhang (136127)

    Published 2025
    “…The inferences reduction significantly decreases the time and FLOPs required by the <i>LazyAct</i> algorithm to complete tasks. …”
  8. 6208

    The source code of LazyAct. by Hongjie Zhang (136127)

    Published 2025
    “…The inferences reduction significantly decreases the time and FLOPs required by the <i>LazyAct</i> algorithm to complete tasks. …”
  9. 6209

    Win rate vs Skip ratios on multi-agents tasks. by Hongjie Zhang (136127)

    Published 2025
    “…The inferences reduction significantly decreases the time and FLOPs required by the <i>LazyAct</i> algorithm to complete tasks. …”
  10. 6210

    Network architectures for multi-agents task. by Hongjie Zhang (136127)

    Published 2025
    “…The inferences reduction significantly decreases the time and FLOPs required by the <i>LazyAct</i> algorithm to complete tasks. …”
  11. 6211
  12. 6212

    Image 1_Anlotinib combined with tislelizumab in the treatment of primary small cell neuroendocrine carcinoma of the prostate: a case report and literature review.jpeg by Xin Fei (20466992)

    Published 2024
    “…The patient was then administered a combination of anlotinib and tislelizumab. After treatment, the patient’s symptoms were controlled, tumor marker levels decreased, and imaging showed significant improvement. …”
  13. 6213
  14. 6214

    Data Sheet 1_A ROS-responsive, aptamer-targeted graphene oxide nanocomposite for site-specific glutathione release in cerebral ischemia-reperfusion injury.docx by Meiying Li (6051287)

    Published 2025
    “…In a Endothelin-1 (ET-1) induced cortical ischemia model, GO@GSH-FA led to a marked decrease in neurological deficit scores (from 7.20 ± 1.16 to 4.20 ± 0.98) and enhanced neuronal survival relative to untreated animals. …”
  15. 6215

    Video1_The immunomodulatory impact of naturally derived neem leaf glycoprotein on the initiation progression model of 4NQO induced murine oral carcinogenesis: a preclinical study.m... by Juhina Das (17808068)

    Published 2024
    “…</p>Methods<p>4NQO was painted on tongue of Swiss mice every third day at a dose of 25µl of 5mg/ml stock solution. After three consecutive treatments with 4NQO (starting Day7), one group of mice was treated with NLGP (s.c. 25μg/mice/week), keeping a group as PBS control. …”
  16. 6216

    DataSheet2_The immunomodulatory impact of naturally derived neem leaf glycoprotein on the initiation progression model of 4NQO induced murine oral carcinogenesis: a preclinical stu... by Juhina Das (17808068)

    Published 2024
    “…</p>Methods<p>4NQO was painted on tongue of Swiss mice every third day at a dose of 25µl of 5mg/ml stock solution. After three consecutive treatments with 4NQO (starting Day7), one group of mice was treated with NLGP (s.c. 25μg/mice/week), keeping a group as PBS control. …”
  17. 6217

    DataSheet1_The immunomodulatory impact of naturally derived neem leaf glycoprotein on the initiation progression model of 4NQO induced murine oral carcinogenesis: a preclinical stu... by Juhina Das (17808068)

    Published 2024
    “…</p>Methods<p>4NQO was painted on tongue of Swiss mice every third day at a dose of 25µl of 5mg/ml stock solution. After three consecutive treatments with 4NQO (starting Day7), one group of mice was treated with NLGP (s.c. 25μg/mice/week), keeping a group as PBS control. …”
  18. 6218

    Table 1_Revealing fitness and virulence determinants of hypervirulent Klebsiella pneumoniae during infection in Galleria mellonella using a transposon library.xlsx by Lisheng Xiao (15919517)

    Published 2025
    “…<p>Klebsiella pneumoniae infections represent a significant public health concern. Despite their clinical relevance, the genetic determinants underlying bacterial fitness and virulence remain incompletely characterized. …”
  19. 6219

    Supplementary file 1_Global burden of pulmonary sarcoidosis from 1990 to 2021: a comprehensive analysis based on the GBD 2021 study.xlsx by Jinming Cao (7837883)

    Published 2025
    “…</p>Results<p>In 2021, global incidence cases reached 390,000, with 43.07 million prevalence cases, 1.88 million deaths and 40.42 million DALYs. Despite decreases in ASR since 1990, absolute numbers rose. …”
  20. 6220

    Table 2_Carnosine as a protective metabolic mediator in inflammatory lung injury by inhibiting macrophage infiltration and M1-like polarization.xlsx by Lianjie Ruan (22660265)

    Published 2025
    “…Multiplex immunofluorescence further demonstrated a significant reduction of macrophage accumulation in the peribronchial regions of the lung following carnosine administration. …”